Srivastava Lab · The Wistar Institute · Philadelphia

Before the protein,
there is choice.

One exon. One cell. One decision at a time.

Splicing is where a gene becomes an isoform — quietly rewritten in both drug-resistant cancer and hyperactivated autoimmune disease. The Srivastava Lab builds the technology and the computation to read those decisions one cell, one isoform at a time.

  • Technology BenchDrop-seq — PIP-seq capture + Oxford Nanopore, on any lab bench
  • Computation Bagpiper — spacer-anchored barcodes and junction-aware isoform counts
  • Biology From NRAS-mutant melanoma to multiple sclerosis and EBV dysregulation
The isoform blindspot — fewer than 5% of transcript isoforms are visible to standard scRNA-seq
5K+
Citations
25+
Publications
10K+
Tool users
4
Research pillars

Biology is currently measured at gene-level resolution, which collapses roughly twenty thousand protein-coding genes into a single number each and erases the more than two hundred thousand isoforms those genes actually produce. The choices hidden inside that collapse — which exon is included, which 3′ end is used, which regulatory feature is decorated — are exactly the choices that drive drug-resistant states in cancer and hyperactivated states in autoimmune disease. The Srivastava Lab builds the technology and the computation needed to read that regulation at isoform resolution, in individual cells, before the protein is ever made.

Measure · Quantify · Integrate · Apply

Four tightly coupled efforts: a benchtop single-cell platform, a long-read isoform quantification pipeline, cross-platform integration, and co-equal biological programs in cancer and autoimmunity.

Built here at Wistar

Open-source platforms and pipelines developed independently in the lab since September 2023. Every method ships with documented, reproducible code.

What’s happening